osimertinib
astrazeneca
['adaura', 'nsclc', 'lcsm,(-blcsm)', 'sclc', 'osimertinib', 'aura ,(-laura)']
#asco23: plenary session adaura trial:impressive overall survival data for adjuvant osimertinib in resected egfr + stages ib-iiia nsclc patients. very proud to have been the firstbmaximum recruiter in spain of this trial #lcsm 
Associate Head Oncology. Fundación Jiménez Díaz. IIS - FJD. Head of Thoracic Oncology & Clinical Trials. Professor  @UAM_Madrid previously @RoyalFreeNHS London